LU91235I2 - Palifermin et ses dérivés pharmaceutiquement acceptables (KEPIVANCE) - Google Patents

Palifermin et ses dérivés pharmaceutiquement acceptables (KEPIVANCE)

Info

Publication number
LU91235I2
LU91235I2 LU91235C LU91235C LU91235I2 LU 91235 I2 LU91235 I2 LU 91235I2 LU 91235 C LU91235 C LU 91235C LU 91235 C LU91235 C LU 91235C LU 91235 I2 LU91235 I2 LU 91235I2
Authority
LU
Luxembourg
Prior art keywords
kepivance
palifermin
pharmaceutically acceptable
acceptable derivatives
derivatives
Prior art date
Application number
LU91235C
Other languages
English (en)
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/487,830 external-priority patent/US6008328A/en
Application filed by Amgen Inc filed Critical Amgen Inc
Publication of LU91235I2 publication Critical patent/LU91235I2/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/50—Fibroblast growth factors [FGF]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
LU91235C 1994-10-13 2006-04-12 Palifermin et ses dérivés pharmaceutiquement acceptables (KEPIVANCE) LU91235I2 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US32333994A 1994-10-13 1994-10-13
US08/487,830 US6008328A (en) 1994-10-13 1995-06-07 Method for purifying keratinocyte growth factors
PCT/US1995/013099 WO1996011952A1 (fr) 1994-10-13 1995-10-12 Procede pour purifier des facteurs de croissance des keratinocytes

Publications (1)

Publication Number Publication Date
LU91235I2 true LU91235I2 (fr) 2006-11-22

Family

ID=26983902

Family Applications (1)

Application Number Title Priority Date Filing Date
LU91235C LU91235I2 (fr) 1994-10-13 2006-04-12 Palifermin et ses dérivés pharmaceutiquement acceptables (KEPIVANCE)

Country Status (18)

Country Link
EP (2) EP1334981B1 (fr)
JP (1) JP3877226B2 (fr)
CN (1) CN1161380C (fr)
AT (1) ATE239038T1 (fr)
CA (1) CA2201762C (fr)
CZ (1) CZ98297A3 (fr)
DE (2) DE69530599T2 (fr)
DK (1) DK0785949T3 (fr)
ES (1) ES2197926T3 (fr)
HU (1) HU220584B1 (fr)
IL (3) IL115605A (fr)
LU (1) LU91235I2 (fr)
NL (1) NL300229I2 (fr)
NO (1) NO971567L (fr)
PT (1) PT785949E (fr)
SI (1) SI0785949T1 (fr)
SK (1) SK43097A3 (fr)
WO (1) WO1996011952A1 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6077692A (en) 1995-02-14 2000-06-20 Human Genome Sciences, Inc. Keratinocyte growth factor-2
US7232667B2 (en) 1995-02-14 2007-06-19 Human Genome Sciences, Inc. Keratinocyte growth factor-2 polynucleotides
US6693077B1 (en) 1995-02-14 2004-02-17 Human Genome Sciences, Inc. Keratinocyte growth factor-2
US6743422B1 (en) 1996-10-15 2004-06-01 Amgen, Inc. Keratinocyte growth factor-2 products
US6238888B1 (en) 1997-12-22 2001-05-29 Human Genone Sciences, Inc. Keratinocyte growth factor-2 formulations
US6869927B1 (en) 1997-12-22 2005-03-22 Human Genome Sciences, Inc. Keratinocyte growth factor-2 formulations
BR0207017A (pt) * 2001-02-06 2004-02-03 Merck Patent Gmbh Fator de crescimento ceratinócito modificado (kgf) com imunogenicidade reduzida
MXPA04001526A (es) * 2001-08-21 2004-05-31 Chiron Corp Composiciones de polipetidos kgf.
CN102242124B (zh) * 2010-05-10 2013-05-22 齐鲁制药有限公司 改造的角化细胞生长因子基因及其在酵母中的表达
CN102675449B (zh) * 2011-03-17 2016-06-08 重庆富进生物医药有限公司 缺失型人角质细胞生长因子-ⅰ二硫键变构体及其用途
CN109402130A (zh) * 2018-11-23 2019-03-01 成都中医药大学附属医院 一种重组人角质细胞生长因子-1及其制备方法和用途
CN110183529B (zh) * 2019-05-23 2023-06-02 重庆派金生物科技有限公司 一种缺失型人角质细胞生长因子-1的重组制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0555205B1 (fr) * 1989-01-31 2000-11-29 RUBIN, Jeffrey S Adn codant un facteur de croissance specifique contre des cellules epitheliales
JPH06503962A (ja) * 1990-12-18 1994-05-12 アムジエン・インコーポレーテツド 増強された安定性及び生物学的活性を有する酸性線維芽細胞成長因子の類似体
NZ266622A (en) * 1993-06-29 1997-10-24 Chiron Corp Keratinocyte growth factor fragment (kgf) with at least a 2-fold increase in mitogenic activity compared to a full length kgf; dna molecules, expression vectors, host cells, and conjugates
JPH09503661A (ja) * 1993-09-24 1997-04-15 アメリカン シアナミド カンパニー 繊維芽細胞成長因子の表面ループ構造アナログ
EP0804479B1 (fr) * 1994-10-13 2006-10-11 Amgen Inc., Procede de traitement du diabete sucre a l'aide du facteur de croissance des keratinocytes
CZ98097A3 (en) * 1994-10-13 1997-12-17 Amgen Inc Acid fibroblast growth factor analogs exhibiting increased stability and biological activity
ES2196088T3 (es) * 1994-10-13 2003-12-16 Amgen Inc Analogos del factor de crecimiento de los queratinocitos.

Also Published As

Publication number Publication date
DK0785949T3 (da) 2003-08-18
IL115605A0 (en) 1996-01-19
NO971567L (no) 1997-06-12
DE69530599T2 (de) 2003-11-13
IL147575A0 (en) 2002-08-14
CZ98297A3 (cs) 1998-08-12
JPH10507452A (ja) 1998-07-21
EP0785949B1 (fr) 2003-05-02
EP0785949A1 (fr) 1997-07-30
JP3877226B2 (ja) 2007-02-07
NL300229I2 (nl) 2006-09-01
WO1996011952A1 (fr) 1996-04-25
CN1169734A (zh) 1998-01-07
MX9702481A (es) 1997-07-31
NL300229I1 (nl) 2006-06-01
HU220584B1 (hu) 2002-03-28
ES2197926T3 (es) 2004-01-16
EP1334981A3 (fr) 2004-05-06
CA2201762C (fr) 2001-12-18
DE122006000019I1 (de) 2006-06-29
CN1161380C (zh) 2004-08-11
PT785949E (pt) 2003-09-30
AU3830695A (en) 1996-05-06
HUT76879A (en) 1997-12-29
NO971567D0 (no) 1997-04-04
AU709362B2 (en) 1999-08-26
ATE239038T1 (de) 2003-05-15
EP1334981B1 (fr) 2011-01-26
CA2201762A1 (fr) 1996-04-25
IL115605A (en) 2003-06-24
SK43097A3 (en) 1998-10-07
IL147575A (en) 2004-05-12
DE69530599D1 (de) 2003-06-05
SI0785949T1 (en) 2003-08-31
EP1334981A2 (fr) 2003-08-13

Similar Documents

Publication Publication Date Title
LU91235I2 (fr) Palifermin et ses dérivés pharmaceutiquement acceptables (KEPIVANCE)
KR950702564A (ko) 비스-스타우로스포린 및 케이-252에이(K-25a)유도체(BIS-STAUROSPORINE AND K-252a DERIVATIVES)
TR200003036T2 (tr) 12,13-Modifiye edilmiş epotilon türevleri
AU1642795A (en) Substituted pyridylpyrazoles
ES2145915T3 (es) Derivados estereoquimicos de la wortmannina.
ES2138691T3 (es) Procedimiento para la obtencion de derivados de n-acil-5-fluorocitidina.
LU91673I2 (fr) "Dronédarone et ses dérivés pharmaceutiquement acceptables (MULTAQ)"
DK0695758T3 (da) Pentapeptidamider og -estere til inhibering af human cancer
DK0876392T3 (da) Lacton-derivater af 17.beta.-carboxy, carbothio og amidandrostanforbindelser
ATE211732T1 (de) N-benzylpiperidin- und tetrahydropyridin-derivate
DK0451547T3 (da) 1,4,8-triazacyclotridecanderivater med prolylendopeptidase inhiberende aktivitet
FR2670669B1 (fr) Instrument de correction chirurgicale de l'astigmatisme.
DK0896544T3 (da) Kombination af en somatostatinanalog og en rapamycin
LU92263I2 (fr) Imépitoïne et ses dérivés pharmaceutiquement acceptables (PEXION)
PT1119359E (pt) Formulacao de 2-metil-tieno-benzodiazepina
GB2380939B (en) Treatment or prevention of auto-immune diseases
TW330933B (en) Furanoeremophilane and eremophilanolide sesquiterpenes for treatment of diabetes
NO990450D0 (no) Behandling av sinnslidelser
ES2156212T3 (es) Derivados de azabicicloheptano n-substituidos como neurolepticos, etc.
FI930092A (fi) Indanopyrrolidinkarbamater
GR3034688T3 (en) Use of 6,7-substituted-2-aminotetralines for preparing pharmaceutical compositions useful for the treatment of septic shock, and antipyretic and antiinflammatory pharmaceutical compositions
NZ336249A (en) parenteral composition of a dihydropolyprenol and a pharmaceutically acceptable oil
TR199701011A2 (xx) 1-karba-(detia)-sefalosforin t�revleri.
BR9712628A (pt) Derivados de 8(9)-deidroestradiol
GR930100335A (el) Ενώσεις και μέ?οδοι αναστολής του ΗΙV και των σχετικών ιών.